Sean Salmon - 25 Aug 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role: EVP & Pres Diabetes/Cardiovasc
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol: MDT
Transactions as of: 25 Aug 2021
Net transactions value: -$2,710,426
Form type: 4
Filing time: 26 Aug 2021, 19:28:40 UTC
Previous filing: 04 Aug 2021
Next filing: 09 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Options Exercise	$820,016	+21,129	+63%	$38.81	54,458	25 Aug 2021	Direct
transaction	MDT	Ordinary Shares	Sale	$2,832,976	-21,129	-39%	$134.08	33,329	25 Aug 2021	Direct	F1
transaction	MDT	Ordinary Shares	Options Exercise	$100,013	+2,577	+7.7%	$38.81	35,906	25 Aug 2021	Direct
transaction	MDT	Ordinary Shares	Options Exercise	$180,037	+4,713	+13%	$38.20	40,619	25 Aug 2021	Direct
transaction	MDT	Ordinary Shares	Sale	$977,516	-7,290	-18%	$134.09	33,329	25 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Stock Option (Right to Buy)	Options Exercise	$0	-21,129	-100%	$0.000000^*	25 Aug 2021	Ordinary Shares	21,129	$38.81	Direct	F2
transaction	MDT	Stock Option (Right to Buy)	Options Exercise	$0	-2,577	-100%	$0.000000^*	25 Aug 2021	Ordinary Shares	2,577	$38.81	Direct	F2
transaction	MDT	Stock Option (Right to Buy)	Options Exercise	$0	-4,713	-100%	$0.000000^*	25 Aug 2021	Ordinary Shares	4,713	$38.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.05 to $134.16 inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant.

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.05 to $134.16 inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant.